FDA inspection
Aesica Pharmaceuticals S.r.l.: FDA inspection ending May 30, 2025
FDA inspection 1275163 · No Action Indicated (NAI) · Pianezza
Key facts
| Inspection ID | 1275163 |
|---|---|
| Firm | Aesica Pharmaceuticals S.r.l. |
| FEI number | 3013548751 |
| Address | Via Praglia N. 15 |
| City | Pianezza |
| Country | Italy |
| Fiscal year | 2025 |
| Inspection end date | May 30, 2025 |
| Classification | No Action Indicated (NAI) |
| Project area | Pre-Approval Eval. of Animal Drugs and Food Additives |
| Product type | Veterinary |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data